398 related articles for article (PubMed ID: 11496348)
1. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
3. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
4. [Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study].
Gadner H; Heitger A; Ritter J; Göbel U; Janka GE; Kühl J; Bode U; Spaar HJ
Klin Padiatr; 1987; 199(3):173-82. PubMed ID: 3498085
[TBL] [Abstract][Full Text] [Related]
5. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.
Grois N; Prayer D; Prosch H; Minkov M; Pötschger U; Gadner H
Pediatr Blood Cancer; 2004 Jul; 43(1):59-65. PubMed ID: 15170891
[TBL] [Abstract][Full Text] [Related]
6. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
Lau LM; Stuurman K; Weitzman S
Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322
[TBL] [Abstract][Full Text] [Related]
8. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
[TBL] [Abstract][Full Text] [Related]
9. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
10. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and diagnosis of langerhans cell hyperplasia].
Zhang K; Zeng H; Chen WQ
Ai Zheng; 2006 Jan; 25(1):88-91. PubMed ID: 16405758
[TBL] [Abstract][Full Text] [Related]
12. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution.
Giona F; Caruso R; Testi AM; Moleti ML; Malagnino F; Martelli M; Ruco L; Giannetti GP; Annibali S; Mandelli F
Cancer; 1997 Nov; 80(9):1786-91. PubMed ID: 9351548
[TBL] [Abstract][Full Text] [Related]
13. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.
Prosch H; Grois N; Prayer D; Waldhauser F; Steiner M; Minkov M; Gadner H
Pediatr Blood Cancer; 2004 Oct; 43(5):594-9. PubMed ID: 15382278
[TBL] [Abstract][Full Text] [Related]
14. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the methods of treatment of histiocytosis X in children in relation to its clinical picture].
Perek D
Probl Med Wieku Rozwoj; 1979; 8():185-219. PubMed ID: 318111
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Langerhans cell histiocytosis in children under one year.
Lau L; Krafchik B; Trebo MM; Weitzman S
Pediatr Blood Cancer; 2006 Jan; 46(1):66-71. PubMed ID: 16261594
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
[TBL] [Abstract][Full Text] [Related]
19. Histiocytic syndromes in children.
Cetingül N; Oztop S; Kavakli K; Ozunan I; Nişli G; Hekimgil M
Turk J Pediatr; 1997; 39(3):287-94. PubMed ID: 9339106
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for diabetes insipidus in langerhans cell histiocytosis.
Grois N; Pötschger U; Prosch H; Minkov M; Arico M; Braier J; Henter JI; Janka-Schaub G; Ladisch S; Ritter J; Steiner M; Unger E; Gadner H;
Pediatr Blood Cancer; 2006 Feb; 46(2):228-33. PubMed ID: 16047354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]